Prognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors.

作者: Yu-Li Song , Run Yu , Xin-Wei Qiao , Chun-Mei Bai , Chong-Mei Lu

DOI: 10.1038/S41598-017-02051-1

关键词: CarcinomaImmunohistochemistryGene expression profilingBisulfite sequencingInsulinomaPathologyNeuroendocrine tumorsBiologySurvival analysisCancer researchDNA methylation

摘要: Prognostic biomarkers for the pancreatic neuroendocrine tumors are needed. Proteomic study on insulinoma has been rarely reported. We identified differential expression of proteins between and their paired tissues by proteomic analysis, evaluated prognostic significance specific in including insulinoma. The select was validated more than 300 using immunohistochemical staining western blot. Methylation UCH-L1 promoter examined methylation PCR sequencing. concurrent α-internexin correlated with prognosis 2 independent collectives patients tumors. Sixty-two 219 were significantly down-regulated up-regulated insulinomas, respectively. Demethylation associated (p = 0.002). better overall survival disease-free combination both cohorts (log rank p = 3.90 × 10−4 p = 3.75 × 10−5, respectively) each cohorts. value also stage II III (p = 0.017 p = 0.006, respectively). could be

参考文章(60)
Anna Fen-Yau Li, Chih-Yi Hsu, Alice Li, Ling-Chen Tai, Wen-Yih Liang, Win-Yin Li, Shyh-Haw Tsay, Jeou-Yuan Chen, A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies. Cancer. ,vol. 112, pp. 274- 283 ,(2008) , 10.1002/CNCR.23159
Ekmel Tezel, Kenji Hibi, Yasushi Kasai, Tsunenobu Takase, Akimasa Nakao, Taiji Yamazaki, Seiji Akiyama, Katsuki Ito, Tetsuro Nagasaka, Hiroshi Nakayama, PGP9.5 as a marker for invasive colorectal cancer. Clinical Cancer Research. ,vol. 8, pp. 192- 195 ,(2002)
Philippe Bertolino, Pedro Luis Herrera, Wei-Min Tong, Zhao-Qi Wang, Chang Xian Zhang, Huguette Casse, Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Research. ,vol. 63, pp. 4836- 4841 ,(2003)
Yanan Cao, Zhibo Gao, Lin Li, Xiuli Jiang, Aijing Shan, Jie Cai, Ying Peng, Yanli Li, Xiaohua Jiang, Xuanlin Huang, Jiaqian Wang, Qing Wei, Guijun Qin, Jiajun Zhao, Xiaolong Jin, Li Liu, Yingrui Li, Weiqing Wang, Jun Wang, Guang Ning, Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1 Nature Communications. ,vol. 4, pp. 2810- ,(2013) , 10.1038/NCOMMS3810
Bei Liu, Laura H. Tang, Zhaojun Liu, Mei Mei, Run Yu, Deepti Dhall, Xin-Wei Qiao, Tai-Ping Zhang, Yu-Pei Zhao, Tong-Hua Liu, Yu Xiao, Jie Chen, Hong-Ding Xiang, Hai-Yan Wu, Chong-Mei Lu, Bin Lv, Ya-Ru Zhou, Ye Zhang, Dajun Deng, Yuan-Jia Chen, α-Internexin: a novel biomarker for pancreatic neuroendocrine tumor aggressiveness. The Journal of Clinical Endocrinology and Metabolism. ,vol. 99, ,(2014) , 10.1210/JC.2013-2874
H J Kim, Y M Kim, S Lim, Y K Nam, J Jeong, H-J Kim, K-J Lee, Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis. Oncogene. ,vol. 28, pp. 117- 127 ,(2009) , 10.1038/ONC.2008.364
Y JONKERS, F RAMAEKERS, E SPEEL, Molecular alterations during insulinoma tumorigenesis. Biochimica et Biophysica Acta. ,vol. 1775, pp. 313- 332 ,(2007) , 10.1016/J.BBCAN.2007.05.004
David C. Metz, Robert T. Jensen, Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology. ,vol. 135, pp. 1469- 1492 ,(2008) , 10.1053/J.GASTRO.2008.05.047
Y. Jiao, C. Shi, B. H. Edil, R. F. de Wilde, D. S. Klimstra, A. Maitra, R. D. Schulick, L. H. Tang, C. L. Wolfgang, M. A. Choti, V. E. Velculescu, L. A. Diaz, B. Vogelstein, K. W. Kinzler, R. H. Hruban, N. Papadopoulos, Daxx/atrx, men1, and mtor pathway genes are frequently altered in pancreatic neuroendocrine tumors Science. ,vol. 331, pp. 1199- 1203 ,(2011) , 10.1126/SCIENCE.1200609